Skip to content
Catalyst

knowcompoundsCrocin-1findings

Every finding on crocin-1

14 findings, by evidence strength

Direction
Strength, at least

14 shown

  1. Pittsburgh Sleep Quality Index global scoreMoved: lowersEvidence: ModeratePaper: PMID 307957852019
    Who
    Patients under methadone maintenance treatment (methadone in both arms); crocin 30 mg/day versus placebo
    Dose studied
    30 mg/day crocin (15 mg twice daily)

    After 8-week intervention, crocin significantly decreased Beck Depression Inventory (b - 6.66; 95% CI, - 9.88, - 3.45; P < 0.0001), Beck Anxiety Inventory (b - 4.35; 95% CI, - 5.94, - 2.75; P < 0.0001), general health questionnaire (b - 4.45; 95% CI, - 7.68, - 1.22; P = 0.008) and Pittsburgh Sleep Quality Index (b - 2.73; 95% CI, - 3.74, - 1.73; P < 0.0001) in patients under MMT, compared with the placebo.”

    Quoted verbatim from The effects of crocin on psychological parameters in patients under methadone maintenance treatment: a randomized clinical trial.RCT · 8 weeksPermalink
  2. TriglyceridescontestedMoved: lowersEvidence: ModeratePaper: PMID 362090912022
    Who
    Adults with type 2 diabetes and microalbuminuria on routine antidiabetic, antihypertensive and lipid-lowering care; crocin 15 mg/day versus placebo
    Dose studied
    15 mg crocin tablet daily

    As listed in Table 2, comparison of the crocin and placebo groups for changes in variables (before- after) showed that mean serum TG levels decreased significantly in the crocin group compared with the increasing values in the placebo group (P-Value = 0.03).”

    Quoted verbatim from Evaluation of therapeutic effects of crocin in attenuating the progression of diabetic nephropathy: a preliminary randomized triple-blind placebo-controlled trial.RCT · 3 monthsPermalink
  3. Beck Depression Inventory (BDI) total scoreMoved: lowersEvidence: ModeratePaper: PMID 307957852019
    Who
    Patients under methadone maintenance treatment (methadone in both arms); crocin 30 mg/day versus placebo
    Dose studied
    30 mg/day crocin (15 mg twice daily)

    After 8-week intervention, crocin significantly decreased Beck Depression Inventory (b - 6.66; 95% CI, - 9.88, - 3.45; P < 0.0001), Beck Anxiety Inventory (b - 4.35; 95% CI, - 5.94, - 2.75; P < 0.0001), general health questionnaire (b - 4.45; 95% CI, - 7.68, - 1.22; P = 0.008) and Pittsburgh Sleep Quality Index (b - 2.73; 95% CI, - 3.74, - 1.73; P < 0.0001) in patients under MMT, compared with the placebo.”

    Quoted verbatim from The effects of crocin on psychological parameters in patients under methadone maintenance treatment: a randomized clinical trial.RCT · 8 weeksPermalink
  4. Fasting blood glucoseMoved: lowersEffect, as reportedMD−6.52[−11.96 to −1.08]Evidence: Very limitedPaper: PMID 329517482020
    Who
    Participants in eight clinical trials of crocin supplementation (nine effect sizes), pooled
    Dose studied
    not reported

    Results of the pooled random-effect size analysis showed just a significant decreasing effect of crocin supplementation on FBG (WMD: -6.52 mg/l, 95 % CI, -11.96, -1.08; p = 0.019) and TC (WMD: -4.64 mg/l, 95 % CI, -8.19, -1.09; p = 0.010).”

    Quoted verbatim from The effect of crocin supplementation on lipid concentrations and fasting blood glucose: A systematic review and meta-analysis and meta-regression of randomized controlled trials.meta-analysisPermalink
  5. Total cholesterol (TC)Moved: lowersEffect, as reportedMD−4.64[−8.19 to −1.09]Evidence: Very limitedPaper: PMID 329517482020
    Who
    Participants in eight clinical trials of crocin supplementation (nine effect sizes), pooled
    Dose studied
    not reported

    Results of the pooled random-effect size analysis showed just a significant decreasing effect of crocin supplementation on FBG (WMD: -6.52 mg/l, 95 % CI, -11.96, -1.08; p = 0.019) and TC (WMD: -4.64 mg/l, 95 % CI, -8.19, -1.09; p = 0.010).”

    Quoted verbatim from The effect of crocin supplementation on lipid concentrations and fasting blood glucose: A systematic review and meta-analysis and meta-regression of randomized controlled trials.meta-analysisPermalink
  6. LDL cholesterolMoved: no difference foundEvidence: Very limitedPaper: PMID 329517482020
    Who
    Participants in eight clinical trials of crocin supplementation (nine effect sizes), pooled
    Dose studied
    not reported

    Crocin supplements did not have any significant effect on serum TG (p = 0.144) levels, LDL-C (p = 0.161), and HDL-C (p = 0.872) levels.”

    Quoted verbatim from The effect of crocin supplementation on lipid concentrations and fasting blood glucose: A systematic review and meta-analysis and meta-regression of randomized controlled trials.meta-analysisPermalink
  7. TriglyceridescontestedMoved: no difference foundEvidence: Very limitedPaper: PMID 329517482020
    Who
    Participants in eight clinical trials of crocin supplementation (nine effect sizes), pooled
    Dose studied
    not reported

    Crocin supplements did not have any significant effect on serum TG (p = 0.144) levels, LDL-C (p = 0.161), and HDL-C (p = 0.872) levels.”

    Quoted verbatim from The effect of crocin supplementation on lipid concentrations and fasting blood glucose: A systematic review and meta-analysis and meta-regression of randomized controlled trials.meta-analysisPermalink
  8. C-reactive protein concentrationMoved: lowersEvidence: Very limitedreplicated ×1Paper: PMID 383068882024
    Who
    Patients with multiple sclerosis; crocin 15 mg twice daily (30 mg/day) versus placebo
    Dose studied
    15 mg crocin tablet twice daily (30 mg/day)

    The data analysis using ANCOVA showed that supplementation with crocin for 8 weeks significantly lowered hs-CRP levels (p-value= 0.01).”

    Quoted verbatim from Effects of crocin on inflammatory biomarkers and mental health status in patients with multiple sclerosis: A randomized, double-blinded clinical trial.RCT · 8 weeksPermalink
  9. C-reactive protein concentrationMoved: lowersEffect, as reportedSMD−0.5[−0.86 to −0.13]Evidence: Very limitedreplicated ×1Paper: PMID 396326022025
    Who
    Adults supplemented with crocin in pooled randomised clinical trials
    Dose studied
    not reported

    Our findings indicated that crocin supplementation significantly reduced c-reactive protein (CRP) levels (SMD: -0.50; 95%CI: -0.86 to -0.13; p = 0.008), tumor necrosis factor-α (TNF-α) (SMD: -1.96; 95%CI: -2.72 to -1.19; p < 0.001), and interleukin-6 (IL-6) (SMD: -3.52; 95%CI: -6.84 to -0.20; p = 0.03).”

    Quoted verbatim from Crocin Supplementation on Inflammation and Oxidative Stress: A Systematic Review and Meta-Analysis.meta-analysisPermalink
  10. Tumour necrosis factor alpha concentrationMoved: lowersEffect, as reportedSMD−1.96[−2.72 to −1.19]Evidence: Very limitedPaper: PMID 396326022025
    Who
    Adults supplemented with crocin in pooled randomised clinical trials
    Dose studied
    not reported

    Our findings indicated that crocin supplementation significantly reduced c-reactive protein (CRP) levels (SMD: -0.50; 95%CI: -0.86 to -0.13; p = 0.008), tumor necrosis factor-α (TNF-α) (SMD: -1.96; 95%CI: -2.72 to -1.19; p < 0.001), and interleukin-6 (IL-6) (SMD: -3.52; 95%CI: -6.84 to -0.20; p = 0.03).”

    Quoted verbatim from Crocin Supplementation on Inflammation and Oxidative Stress: A Systematic Review and Meta-Analysis.meta-analysisPermalink
  11. Total antioxidant capacityMoved: raisesEffect, as reportedSMD1.48[0.52 to 2.43]Evidence: Very limitedPaper: PMID 396326022025
    Who
    Adults supplemented with crocin in pooled randomised clinical trials
    Dose studied
    not reported

    Also, crocin supplementation led to a significant increase in total antioxidant capacity (TAC) (SMD: 1.48; 95%CI: 0.52 to 2.43; p = 0.002).”

    Quoted verbatim from Crocin Supplementation on Inflammation and Oxidative Stress: A Systematic Review and Meta-Analysis.meta-analysisPermalink
  12. Interleukin-6 concentrationMoved: lowersEffect, as reportedSMD−3.52[−6.84 to −0.2]Evidence: Very limitedPaper: PMID 396326022025
    Who
    Adults supplemented with crocin in pooled randomised clinical trials
    Dose studied
    not reported

    Our findings indicated that crocin supplementation significantly reduced c-reactive protein (CRP) levels (SMD: -0.50; 95%CI: -0.86 to -0.13; p = 0.008), tumor necrosis factor-α (TNF-α) (SMD: -1.96; 95%CI: -2.72 to -1.19; p < 0.001), and interleukin-6 (IL-6) (SMD: -3.52; 95%CI: -6.84 to -0.20; p = 0.03).”

    Quoted verbatim from Crocin Supplementation on Inflammation and Oxidative Stress: A Systematic Review and Meta-Analysis.meta-analysisPermalink
  13. HDL cholesterolMoved: no difference foundEvidence: Very limitedPaper: PMID 329517482020
    Who
    Participants in eight clinical trials of crocin supplementation (nine effect sizes), pooled
    Dose studied
    not reported

    Crocin supplements did not have any significant effect on serum TG (p = 0.144) levels, LDL-C (p = 0.161), and HDL-C (p = 0.872) levels.”

    Quoted verbatim from The effect of crocin supplementation on lipid concentrations and fasting blood glucose: A systematic review and meta-analysis and meta-regression of randomized controlled trials.meta-analysisPermalink
  14. Malondialdehyde (circulating)Moved: no difference foundEvidence: Very limitedPaper: PMID 396326022025
    Who
    Adults supplemented with crocin in pooled randomised clinical trials
    Dose studied
    not reported

    Overall effect size showed that crocin intake failed to change the erythrocyte sedimentation rate (ESR) and malondialdehyde (MDA) levels significantly.”

    Quoted verbatim from Crocin Supplementation on Inflammation and Oxidative Stress: A Systematic Review and Meta-Analysis.meta-analysisPermalink

No dose is advised.